跳至主要内容
临床试验/CTRI/2023/02/049589
CTRI/2023/02/049589尚未招募未知

Comparison of nalbuphine as an adjuvant to levobupivacaine heavy 0.5% versus ropivacaine heavy 0.75% intrathecally for surgeries under subarachnoid block : a prospective randomised comparative study.

Mahatma Gandhi medical college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. patient scheduled for elective surgery under subarachnoid block
  • 2. patient of either gender aged 18-60 years
  • 3. patient under ASA I / II/ III
  • 4. patients with written and informed consent

排除标准

  • 1. patient under ASA GRADE III / IV / and V
  • 2. patient allergic to study drugs.
  • 3. non consenting patient.

研究者

相似试验